AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 194 filers reported holding AXSOME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,303,268 | +37.3% | 73,800 | +17.9% | 0.12% | +45.0% |
| Q1 2023 | $3,861,168 | -82.3% | 62,600 | -77.9% | 0.08% | -84.2% |
| Q4 2022 | $21,858,642 | +245.2% | 283,400 | +99.7% | 0.50% | +219.6% |
| Q3 2022 | $6,332,000 | -49.9% | 141,900 | -57.0% | 0.16% | -52.4% |
| Q2 2022 | $12,631,000 | -17.4% | 329,800 | -10.8% | 0.33% | -6.7% |
| Q1 2022 | $15,298,000 | +131.7% | 369,600 | +111.5% | 0.36% | +129.7% |
| Q4 2021 | $6,602,000 | +21.0% | 174,747 | +5.6% | 0.16% | +2.6% |
| Q3 2021 | $5,455,000 | – | 165,500 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |